Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kaken Pharmaceutical Co.

Kaken Pharmaceutical Co.
PUBLIC STATUS
1K-5K EMPLOYEES
4521 STOCK SYMBOL
$53.53 SHARE PRICE (As of Friday Closing)
Description

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Tokyo
  • Japan
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kaken Pharmaceutical Co.’s full profile, request a free trial.

Kaken Pharmaceutical Co. Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$41.11 - $54.80 $2.08B $52.50 $4.21 105K 38.9M

Kaken Pharmaceutical Co. Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 1,358,226 1,372,480 2,020,443 2,065,188
Revenue 831,462 849,322 887,951 941,297
EBITDA 234,369 244,297 269,014 304,989
Net Income 167,126 160,318 171,786 203,200
Total Assets 1,441,189 1,406,797 1,434,244 1,207,977
Total Debt 35,913 34,948 36,464 34,658
Public Fundamental Data provided by Morningstar, Inc. disclaimer